Description
Phase
Phase 3 - a treatment has shown activity against a particular disease, where it is either added to existing treatment or compared to the standard treatment.Inclusion and Exclusion Criteria
Please contact Carryl Du Bois to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- University of Southern California, Los Angeles, California, 90089
-
Arizona
- Arizona Oncology Associates, Tucson, Arizona, 85710
-
Utah
- University of Utah Health Sciences Center, Salt Lake City, Utah, 84132
-
Illinois
- Bleeding & Clotting Disorders Institute, Peoria, Illinois, 61614
-
Ohio
- Signal Point Clinical Research Center LLC, Middletown, Ohio, 45042
Powered by
SC CTSI